Why is Transgene Biotek falling/rising?

As of 03-Jul, Transgene Biotek Ltd's stock price is currently at 4.73, reflecting an increase of 0.04 or 0.85%. The stock has shown a positive trend recently, gaining 3.05% over the last two days and outperforming the sector by a slight margin. In the past week, the stock has risen by 4.88%, while over the past month, it has increased by 15.93%. However, despite these gains, the stock has underperformed significantly on a year-to-date basis, down 30.75%, and has seen a substantial decline of 47.03% over the past year. The stock's moving averages indicate it is performing better than the 5-day, 20-day, 50-day, and 100-day averages, although it remains below the 200-day moving average. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 191.14% against the 5-day average, suggesting growing interest in the stock.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 3.10% over the past month, Transgene Biotek's performance has been significantly stronger, with a 15.93% increase in the same period. However, the stock's year-to-date performance remains concerning, as it lags behind the Sensex's 6.53% gain. This disparity highlights the stock's volatility and the challenges it faces in recovering from its substantial losses over the longer term. Overall, while recent trends indicate a positive short-term movement for Transgene Biotek, the broader context reveals ongoing struggles relative to the market and historical performance.